Elutia ELUT
NASDAQ ELUT
$0.84 +0.04 (+5.30%)
As of: Sep 10, 2026 · 12:14 PM EDT

Elutia (ELUT) Income from Continuing Operations (2019 - 2026)

Elutia's (ELUT) quarterly Income from Continuing Operations came in at -$7.6 million in Q2 2026, down 7.83% year-over-year from -$8.3 million in Q2 2025, and up 3.14% quarter-over-quarter from -$7.9 million in Q1 2026.

Analysis

Elutia (ELUT) Income from Continuing Operations (2019 - 2026) Analysis & Trends

Elutia has disclosed Income from Continuing Operations across 8 years of filings, most recently posting -$7.6 million for Q2 2026.

  • In Q2 2026, Income from Continuing Operations fell 7.83% year-over-year to -$7.6 million; the TTM figure through Jun 2026 stood at -$19.1 million (down 49.54% YoY), while the FY2025 annual figure was -$12.6 million, up 72.28% from the prior year.
  • Income from Continuing Operations came in at -$7.6 million for Q2 2026 at Elutia, up from -$7.9 million in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of $3.3 million in Q3 2024 to a low of -$28.4 million in Q2 2024.
  • Average Income from Continuing Operations over 5 years is -$8.6 million, with a median of -$7.8 million recorded in 2023.
  • Year-over-year, Income from Continuing Operations surged 139.19% in 2024 and plunged 318.34% in 2026.
  • Over 5 years, Income from Continuing Operations stood at -$6.0 million in 2022, then plunged by 153.07% to -$15.2 million in 2023, then surged by 53.0% to -$7.2 million in 2024, then jumped by 55.15% to -$3.2 million in 2025, then tumbled by 138.27% to -$7.6 million in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were -$7.6 million in Q2 2026, -$7.9 million in Q1 2026, and -$3.2 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 181.19 Bn 175.58 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.13 Bn 108.31 Bn 6.34 Bn 1.48 Bn
4 Stryker 104.67 Bn 101.20 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 64.48 Bn 63.94 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.97 Bn 45.72 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.06 Bn 31.61 Bn 1.68 Bn -92.00 Mn
8 Dexcom 32.37 Bn 30.43 Bn 830.00 Mn 249.10 Mn
9 Steris 20.76 Bn 20.28 Bn 684.20 Mn 201.00 Mn
10 Elutia 37.26 Mn 17.36 Mn 1.45 Mn -7.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -7.65 Mn
Mar 31, 2026 -7.89 Mn
Dec 31, 2025 -3.21 Mn
Sep 30, 2025 -383,000.00
Jun 30, 2025 -7.09 Mn
Mar 31, 2025 -1.89 Mn
Dec 31, 2024 -7.16 Mn
Sep 30, 2024 3.34 Mn
Jun 30, 2024 -28.36 Mn
Mar 31, 2024 -17.99 Mn
Dec 31, 2023 -15.22 Mn
Sep 30, 2023 -8.52 Mn
Jun 30, 2023 -7.73 Mn
Mar 31, 2023 -9.78 Mn
Dec 31, 2022 -6.02 Mn
Sep 30, 2022 -11.03 Mn
Jun 30, 2022 -9.40 Mn
Mar 31, 2022 -8.15 Mn
Dec 31, 2021 -9.06 Mn
Sep 30, 2021 -8.32 Mn